Serial alterations in digital hemodynamics and endothelin-1 immunoreactivity, platelet-neutrophil aggregation, and concentrations of nitric oxide, insulin, and glucose in blood obtained from horses following carbohydrate overload

American Journal of Veterinary Research

Volumn 68, Issue 1, 2007, Pages 87-94

  Eades, Susan C ^a   Stokes, Ashley M ^a   Johnson, Philip J ^c   LeBlanc, Casey J ^b,d   Ganjam, Venkataseshu K ^c   Buff, Preston R ^c   Moore, Rustin M ^a  

^a LOUISIANA STATE UNIVERSITY   (United States)

^b LOUISIANA STATE UNIVERSITY   (United States)

^c UNIVERSITY OF MISSOURI   (United States)

^d UNIVERSITY OF TENNESSEE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOHYDRATE; ENDOTHELIN 1; ENDOTHELIN 1 ANTAGONIST; ENDOTHELIN 1 DERIVATIVE; GLUCOSE; INSULIN; NITRIC OXIDE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; ENDOTHELIUM LESION; GLUCOSE BLOOD LEVEL; HEMODYNAMIC MONITORING; HORSE DISEASE; IMMUNOREACTIVITY; INSULIN BLOOD LEVEL; JUGULAR VEIN; LAMINITIS; NEUTROPHIL; NONHUMAN; PATHOGENESIS; PROTEIN BLOOD LEVEL; QUANTITATIVE ANALYSIS; RANDOMIZATION; SKIN DEFECT; THROMBOCYTE AGGREGATION;

ANIMALS; BLOOD GLUCOSE; BLOOD PLATELETS; CARBOHYDRATES; ENDOTHELIN-1; ENZYME-LINKED IMMUNOSORBENT ASSAY; FOOT DISEASES; FORELIMB; HEMATOCRIT; HOOF AND CLAW; HORSE DISEASES; HORSES; INSULIN; LEUKOCYTE COUNT; NEUTROPHILS; NITRIC OXIDE; PLATELET AGGREGATION;

ANIMALIA; EQUIDAE;

EID: 33846507990     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: 10.2460/ajvr.68.1.87     Document Type: Article

References (48)

1. Garner HE, Hahn AW, Salem C, et al. Cardiac output, left ventricular ejection rate, plasma volume, and heart rate changes in equine laminitis-hypertension. Am J Vet Res 1977;38:725-729.
2. Eades SC, Holm AS, Moore RM. Effects of an endothelin receptor antagonist and nitroglycerine on digital microvascular function in horses during the prodromal stages of carbohydrate overload laminitis. Am J Vet Res 2006;67:1204-1211.
3. Allen D Jr, Clark ES, Moore JN, et al. Evaluation of equine digital Starling forces and hemodynamics during early laminitis. Am J Vet Res 1990;51:1930-1934.
4. Hood DM, Wagner IP, Brumbaugh GW. Evaluation of hoof wall surface temperature as an index of digital vascular perfusion during the prodromal and acute phases of carbohydrate-induced laminitis in horses. Am J Vet Res 2001;62:1167-1172.
5. Eaton SA, Allen D, Eades SC, et al. Digital Starling forces and hemodynamics during early laminitis induced by an aqueous extract of black walnut (Juglans nigra) in horses. Am J Vet Res 1995;56:1338-1344.
6. Pollitt CC, Davies CT. Equine laminitis: its development coincides with increased sublamellar blood flow. Equine Vet J Suppl 1998;(26):125-132.
7. Robinson NE, Scott JB, Dabney JM, et al. Digital vascular responses and permeability in equine alimentary laminitis. Am J Vet Res 1976;37:1171-1176.
8. Kirker-Head CA, Stephens KA, Toal RL, et al. Circulatory and blood gas changes accompanying the development and treatment of induced laminitis. Equine Vet Sci 1986;6:293-301.
9. Trout DR, Hornof WJ, Linford RL, et al. Scintigraphic evaluation of digital circulation during the developmental and acute phases of equine laminitis. Equine Vet J 1990;22:416-421.
10. Adair HS III, Goble DO, Schmidhammer JL, et al. Laminar microvascular flow, measured by means of laser Doppler flow-metry, during the prodromal stages of black walnut-induced laminitis in horses. Am J Vet Res 2000;61:862-868.
11. Katwa LC, Johnson PJ, Ganjam VK, et al. Expression of endothelin in equine laminitis. Equine Vet J 1999;31:243-247.
12. Schneider DA, Parks AH, Eades SC, et al. Palmar digital vessel relaxation in healthy horses and in horses given carbohydrate. Am J Vet Res 1999;60:233-239.
13. Weiss DJ, Geor RJ, Johnston G, et al. Microvascular thrombosis associated with onset of acute laminitis in ponies. Am J Vet Res 1994;55:606-612.
14. Weiss DJ, Evanson OA, McClenahan D, et al. Effect of a competitive inhibitor of platelet aggregation on experimentally induced laminitis in ponies. Am J Vet Res 1998;59:814-817.
15. Snyder F. Platelet-activating factor and related acetylated lipids as potent biologically active cellular mediators. Am J Physiol 1990;259:C697-V708.
16. Anfossi G, Cavalot F, Massucco P, et al. Insulin influences immunoreactive endothelin release by human vascular smooth muscle cells. Metabolism 1993;42:1081-1083.
17. Ferri C, Pittoni V, Piccoli A, et al. Insulin stimulates endothelin-1 secretion from human endothelial cells and modulates its circulating levels in vivo. J Clin Endocrinol Metab 1995;80:829-835.
18. Piatti P, Monti LD, Conti M, et al. Hypertriglyceridemia and hyperinsulinemia are potent inducers of endothelin-1 release in humans. Diabetes 1996;45:316-321.
19. Wolpert H, Steen SN, Istfan NW, et al. Insulin modulates circulating endothelin-1 levels in humans. Metabolism 1993;42:1027-1030.
20. Juan C, Shen Y, Chien Y, et al. Insulin infusion induces endothelin-1-dependent hypertension in rats. Am J Physiol 2004;287:E948-E954.
21. Schott H. Equine Cushing's syndrome associated with pars intermedia dysfunction. Vet Clin North Am Equine Pract 2002;18:237-270.
22. Field JR, Jeffcott LB. Equine laminitis - another hypothesis for pathogenesis. Med Hypotheses 1989;30:203-210.
23. Consentino F, Luscher TF. Endothelial dysfunction in diabetes mellitus. J Cardiovasc Pharmacol 1998;32(suppl 3):S54-S61.
24. Luscher TF, Dohi Y, Tanner FC, et al. Endothelium-dependent control of vascular tone: effects of age, hypertension and lipids. Basic Res Cardiol 1991;86(suppl 2):143-158.
25. Scheikofer S, Balletshofer B, Andrassy M. Endothelial dysfunction in diabetes mellitus. Semin Thromb Hemost 2000;26:503-511.
26. Pass MA, Pollitt S, Pollitt CC. Decreased glucose metabolism causes separation of hoof lamellae in vitro: a trigger for laminitis? Equine Vet J Suppl 1998;(26):133-138.
27. Mobasheri A, Critchlow K, Clegg PD, et al. Chronic equine laminitis is characterized by loss of GLUT-1, GLUT-4, and ENaC positive laminar keratinocytes. Equine Vet J 2004;36:248-254.
28. Ingle-Fehr JE, Baxter GM. Evaluation of digital and laminar blood flow in horses given a low dose of endotoxin. Am J Vet Res 1998;59:192-196.
29. Garner HE, Coffman JR, Hahn AW, et al. Equine laminitis of alimentary origin: an experimental model. Am J Vet Res 1975;36:441-444.
30. Tetens J, Moore RM, Hosgood GL, et al. Effects of infusion of adenosine triphosphate-magnesium chloride on cardiopulmonary and clinicopathologic variables, cytokine activity and endothelin concentrations in horses administered a low dose of endotoxin. Am J Vet Res 2004;65:225-237.
31. Freestone JF, Wolfsheimer KJ, Kamerling SG, et al. Exercise induced hormonal and metabolic changes in Thoroughbred horses: effects of conditioning and acepromazine. Equine Vet J 1991;23:219-223.
32. Kronfeld DS, Treiber KH, Geor RJ. Comparison of nonspecific indications and quantitative methods for the assessment of insulin resistance in horses and ponies. J Am Vet Med Assoc 2005;226:712-719.
33. Korthuis RJ, Granger DN, Taylor AE. A new method for estimating skeletal muscle capillary pressure. Am J Physiol 1984;246:H880-H885.
34. Ramaswamy CM, Eades SC, Venugopal CS, et al. Plasma concentrations of endothelin-like immunoreactivity in healthy horses and horses with naturally acquired gastrointestinal tract disorders. Am J Vet Res 2002;63:454-458.
35. Wagner OF, Christ G, Wojta J, et al. Polar secretion of endothelin-1 by cultured endothelial cells. J Biol Chem 1992;267:16066-16068.
36. Ekelund U, Adner M, Edvinsson L, et al. Effects of the combined ETA and ETB receptor antagonist PD145065 on arteries, arterioles, and veins in the cat hindlimb. J Cardiovasc Pharmacol 1995;26:S211-S213.
37. Tanus-Santos JE, Gordo WM, Udelsmann A, et al. Nonselective endothelin-receptor antagonism attenuates hemodynamic changes after massive pulmonary air embolism in dogs. Chest 2000;118:175-179.
38. Robinson NE. Digital blood flow, arteriovenous anastomoses and laminitis. Equine Vet J 1990;22:381-383.
39. Weiss DJ. Equine laminitis: a review of recent research. Equine Pract 1997;19:16-20.
40. Hood DM, Amoss MS, Hightower D. Equine laminitis I: radio-isotopic analysis of the hemodynamics of the foot during the acute disease. J Equine Med Surg 1978;2:439-444.
41. Schmidt O, Deegen E, Fuhrmann H, et al. Effects of fat feeding and energy level on plasma metabolites and hormones in Shetland ponies. J Vet Med A Phsyiol Pathol Clin Med 2001;48:39-49.
42. Moore JN, Garner HE, Coffman JR. Haematological changes during development of acute laminitis hypertension. Equine Vet J 1981;13:240-242.
43. Johnson PJ, Messer NT, Ganjam VK. Cushing's syndromes, insulin resistance, and endocrinopathic laminitis. Equine Vet J 2004;36:194-198.
44. Keen JA, McLaren M, Chandler KJ, et al. Biochemical indices of vascular function, glucose metabolism, and oxidative stress in horses with equine Cushing's disease. Equine Vet J 2004;36:226-229.
45. Said SA, Ammar el SM, Suddek GM. Effects of bosentan (ETA/ETB receptor antagonist) on metabolic changes during stress and diabetes. Pharmacol Res 2005;51:107-115.
46. Weiss DJ, Evanson OA, McClenahan D, et al. Evaluation of platelet activation and platelet-neutrophil aggregates in ponies with alimentary laminitis. Am J Vet Res 1997;58:1376-1380.
47. Uhlmann D, Glasser S, Gaebel G, et al. Improvement of post-ischemic hepatic microcirculation after endothelin A receptor blockade-endothelin antagonism influences platelet-endothelium interactions. J Gastrointest Surg 2005;9:187-197.
48. Uhlmann D, Glasser S, Lauer H, et al. Endothelin-a receptor blockade improves postischemic hepatic microhemodynamics. J Cardiovasc Pharmacol 2004;44(suppl 1):S103-S104.